Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Appeals Panel to Hold Avastin Hearing This Week
WSJ Online
Monday, June 27, 2011 - 8:50am
tags:
FDA, Avastin, Roche, breast cancer
Collplant Jumps Most in 7 Months on Development With Pfizer
Bloomberg
Sunday, June 26, 2011 - 12:11pm
tags:
Collplant, Pfizer
Collplant, Pfizer Complete First Stage of Development Project
Bloomberg
Sunday, June 26, 2011 - 12:10pm
tags:
Collplant, Pfizer
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sunday, June 26, 2011 - 12:09pm
tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, diabetes
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sunday, June 26, 2011 - 12:03pm
tags:
Dendreon, prostate cancer, DN24-02, Neuvenge, Provenge, Oncothyreon, Stimuvax, colorectal cancer, breast cancer, Keryx
The Next Big Thing In Biotech: Dendreon
The Street
Sunday, June 26, 2011 - 11:59am
tags:
Dendreon
The 5 Companies in the Pharmaceuticals Industry With the Lowest P/E Ratio (SKBI, BSPM, DEPO, POZN, LLY)
Investor's Business Daily
Saturday, June 25, 2011 - 9:08pm
tags:
Skystar Bio-Pharmaceutical, Pozen, Biostar Pharmaceuticals, Depomed
AstraZeneca: Dividend Dynamo or Blowup?
Motley Fool
Saturday, June 25, 2011 - 8:59pm
tags:
AstraZeneca
Pfizer ponders 'strategic transaction' with Icagen
Yahoo/AP
Saturday, June 25, 2011 - 8:57pm
tags:
Pfizer, Icagen, M&A
Bristol-Myers Experimental Diabetes Drug Safe After 2 Years, Study Shows
Bloomberg
Saturday, June 25, 2011 - 8:44pm
tags:
Bristol-Myers Squibb, AstraZeneca
Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 8:43pm
tags:
Lyxumia, diabetes, Sanofi
Two-Year Data Comparing Cardiovascular Events with Linagliptin and the Sulfonylurea, Glimepiride, Presented as Late-Breaking Poster at ADA
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 8:42pm
tags:
linagliptin, sulfonylurea, glimepiride, diabetes, Boehringer Ingelheim, Eli Lilly
New Phase III Data and Pooled Analysis for Linagliptin Show Improved Blood Sugar Control in Adults With Type 2 Diabetes When Used Alone and With Metformin
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 12:03pm
tags:
linagliptin, Boehringer Ingelheim, Eli Lilly, diabetes
Faruqi & Faruqi, LLP Announces Investigation of Cephalon, Inc.
Yahoo/BusinessWire
Saturday, June 25, 2011 - 12:01pm
tags:
Cephalon
Pacific Biosciences—A Spec Stock Worth the Risk?
CNBC
Saturday, June 25, 2011 - 11:59am
tags:
Pacific Biosciences, DNA sequencing
AIDS Research Alliance to test GeoVax HIV vaccine
bizjournals.com
Saturday, June 25, 2011 - 11:57am
tags:
GeoVax Labs, HIV
Halozyme's Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 11:56am
tags:
Halozyme, Aspart-PH20, Novolog, insulin pumps, diabetes
Analysis Finds Byetta Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
Yahoo/PR NewsWire
Saturday, June 25, 2011 - 11:53am
tags:
Byetta, Amylin, diabetes
Ozone Pharma gets patent for molecule of diabetic retinopathy
Pharmabiz
Saturday, June 25, 2011 - 11:51am
tags:
Ozone Pharma, diabetic retinopathy
Zafgen Announces Cardiovascular Data from Phase 1b Study of ZGN-433 in Obesity at American Diabetes Association Annual Meeting
Enhanced Online News
Saturday, June 25, 2011 - 11:25am
tags:
Zafgen, ZGN-433, obesity, weight loss

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.